tiprankstipranks

Life Sciences at Goldman Sachs Alternatives Investment Portfolio

Life Sciences at Goldman Sachs Alternatives is the life sciences investment team within Goldman Sachs Asset Management’s Alternatives platform. The team makes private investments in biotechnology, pharmaceutical and medical technology companies, providing growth- and venture-stage capital across the life sciences sector.

Companies Invested In

Company Name
Sector
Investment Round Value
Funding Round
Announcement Date
Healthcare, Biotechnology & Medical Devices
$75.00M
Series C
Jan 08, 2026
Healthcare, Biotechnology & Medical Devices
$52.00M
Series A
Feb 04, 2026